Ofloxacin otic is as effective in curing otitis externa in children (<12 ye
ars of age) as is the preparation combining polymyxin/neomycin plus hydroco
rtisone and as ciprofloxacin otic. Furthermore ofloxacin otic, as it requir
es less frequent dosing, is likely to encourage greater patient adherence a
nd consequently to achieve a better cure rate than both of these treatment
options. Because a number of cases of otitis externa are complicated by an
undiagnosed tympanic membrane perforation, the lack of ototoxicity associat
ed with ofloxacin otic makes it a particularly safe option for use in these
patients.